Stockholders' Equity	9 Months Ended
Sep. 30, 2018
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Preferred Stock There were no issuances of preferred stock during the nine month periods ended September 30, 2018 and 2017. Common Stock The Company is authorized to issue 110,000,000 shares of common stock, $.001 par value per share. As of September 30, 2018, there were 84,062,446 shares issued (including 980,851 restricted stock awards issued, of which 300,000 were unvested) and 83,762,446 shares of common stock outstanding. There were no shares of common stock issued as a result of the vesting of restricted stock awards (RSA) or stock option exercises during the three month period ended September 30, 2018. The Company issued 102,525 shares of common stock, as a result of the vesting of a portion of RSAs during the three month period ended September 30, 2017. See Note 12 for additional information regarding RSA activity. There were no shares of common stock issued as a result of stock option exercises during the three month periods ended September 30, 2018 and 2017. Shares of common stock issued as a result of stock option exercises and realized gross proceeds during the nine month period ended September 30, 2018 were 50,000 and $22,000, respectively. Shares of common stock issued as a result of stock option exercises and realized gross proceeds during the nine month period ended September 30, 2017 were 30,000 and $17,100, respectively. See Note 12 for additional information regarding the stock incentive plans.

Stockholders' Equity

9 Months Ended

Sep. 30, 2018

Stockholders' Equity Note [Abstract]

Preferred Stock

There were no issuances of preferred stock during the nine month periods ended September 30, 2018 and 2017.

Common Stock

The Company is authorized to issue 110,000,000 shares of common stock, $.001 par value per share. As of September 30, 2018, there were 84,062,446 shares issued (including 980,851 restricted stock awards issued, of which 300,000 were unvested) and 83,762,446 shares of common stock outstanding. There were no shares of common stock issued as a result of the vesting of restricted stock awards (RSA) or stock option exercises during the three month period ended September 30, 2018. The Company issued 102,525 shares of common stock, as a result of the vesting of a portion of RSAs during the three month period ended September 30, 2017. See Note 12 for additional information regarding RSA activity.

There were no shares of common stock issued as a result of stock option exercises during the three month periods ended September 30, 2018 and 2017. Shares of common stock issued as a result of stock option exercises and realized gross proceeds during the nine month period ended September 30, 2018 were 50,000 and $22,000, respectively. Shares of common stock issued as a result of stock option exercises and realized gross proceeds during the nine month period ended September 30, 2017 were 30,000 and $17,100, respectively. See Note 12 for additional information regarding the stock incentive plans.